Cargando…
Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis
BACKGROUND: The consensus molecular subtypes (CMSs) of colorectal cancer (CRC) capture tumor heterogeneity at the gene-expression level. Currently, a restricted number of molecular features are used to guide treatment for CRC. We summarize the evidence on the clinical value of the CMSs. METHODS: We...
Autores principales: | ten Hoorn, Sanne, de Back, Tim R, Sommeijer, Dirkje W, Vermeulen, Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002278/ https://www.ncbi.nlm.nih.gov/pubmed/34077519 http://dx.doi.org/10.1093/jnci/djab106 |
Ejemplares similares
-
Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone
por: ten Hoorn, Sanne, et al.
Publicado: (2021) -
Evaluation of Systemic Treatments of Small Intestinal Adenocarcinomas: A Systematic Review and Meta-analysis
por: de Back, Tim, et al.
Publicado: (2023) -
Development of a miRNA‐based classifier for detection of colorectal cancer molecular subtypes
por: Adam, Ronja S., et al.
Publicado: (2022) -
Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data
por: Trinh, Anne, et al.
Publicado: (2018) -
The Consensus Molecular Subtypes of Colorectal Cancer
por: Guinney, Justin, et al.
Publicado: (2015)